BRIEF-NIP Group Inc- Anticipate That US Initial Public Offering Price Will Be Between US$9.00 And US$11.00 Per ADS.-February 2024-www.financetom.com

BRIEF-NIP Group Inc- Anticipate That US Initial Public Offering Price Will Be Between US$9.00 And US$11.00 Per ADS.

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-NIP Group Inc- Anticipate That US Initial Public Offering Price Will Be Between US$9.00 And US$11.00 Per ADS.

Jul 5, 2024 2:06 PM

July 5 (Reuters) -

* NIP GROUP INC- ANTICIPATE THAT US INITIAL PUBLIC OFFERING

PRICE

WILL BE BETWEEN US$9.00 AND US$11.00 PER ADS.

* NIP GROUP INC. SAYS NOW SEES US IPO OF UP TO 2.25 MILLION

ADSS -

SEC FILING

* NIP GROUP INC. SAYS REMOVED DEUTSCHE BANK , CICC, SAHM

CAPITAL AS UNDERWRITERS TO US IPO

* NIP GROUP INC- ADDED CLSA AMONG UNDERWRITERS TO US IPO

Source text for Eikon:

Previous page： Diamondback Energy Unveils Sale of Mineral, Royalty Interest to Viper Energy Next page： US FDA approves Vertex's non-opioid painkiller

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Diamondback Energy Unveils Sale of Mineral, Royalty Interest to Viper Energy

Jan 30, 2025

05:58 PM EST, 01/30/2025 (MT Newswires) -- Diamondback Energy ( FANG ) entered an agreement to sell certain mineral and royalty-interests owning subsidiaries to its publicly-listed subsidiary Viper Energy ( VNOM ) for $1 billion in cash and about 69.6 million units of Viper's operating subsidiary Viper Energy Partners, Viper said Thursday. Viper expects to fund the cash portion of...

US FDA approves Vertex's non-opioid painkiller

Jan 30, 2025

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' ( VRTX ) drug to treat acute pain, the health regulator said on Thursday, offering an alternative to addictive opioid painkillers that have fueled a national crisis. ...

Emerald Completes $515 Million Loan Refinancing, Extends Credit Maturity

Jan 30, 2025

05:56 PM EST, 01/30/2025 (MT Newswires) -- Emerald Holding ( EEX ) said Thursday it completed the refinancing of its existing first lien term loan with a $515 million senior secured term loan facility. The new upsized seven-year facility matures on Jan. 30, 2032, according to the company. Additionally, Emerald extended the maturity of its $110 million senior secured revolving...

Avid Shareholders Approve Acquisition by GHO, Ampersand

Jan 30, 2025

05:59 PM EST, 01/30/2025 (MT Newswires) -- Avid Bioservices ( CDMO ) said late Thursday it has obtained shareholder approval for its acquisition by GHO Capital Partners and Ampersand Capital Partners. The transaction is now expected to close in the coming days, the company said. ...